在阿尔茨海默病中,选择基因变异与脂质特征的变异性之间的关联:前性观察研究
Fabricio Ferreira de Oliveira1, Sandro Soares de Almeida2, Elizabeth Suchi Chen3
1MD, MSc, PhD, FAAN. Departamento de Neurologia e Neurocirurgia, Escola Paulista de Medicina, Universidade Federal de São Paulo (Unifesp), São Paulo (SP), Brazil.
Sao Paulo medical journal = Revista paulista de medicina
|August 20, 2025
概括
遗传变异会影响阿尔茨海默病患者的脂质特征. 根据特定的遗传标记,特别是对于高脂胆固醇,他的反应有所不同,这证实了脂质代谢的遗传性.
科学领域:
- 药物遗传学
- 神经退行性疾病
- 脂肪新陈代谢
背景情况:
- 脂质特征受到遗传变异的显著影响.
- 脂质代谢是阿尔茨海默病 (AD) 发病过程中不可或缺的组成部分.
研究的目的:
- 研究与胆固醇代谢相关的遗传变异如何影响阿尔茨海默病患者对不同类型他的反应.
- 探索阿尔茨海默病中他类药物治疗的药物遗传基础.
主要方法:
- 一项前性观察性药物遗传研究,涉及圣保罗联邦大学的189名门诊患者.
- 在一年内对脂质概况进行了监测,以评估他类药物治疗与遗传变异之间的关联 (例如,APOE,CETP,HMGCR,LDLR,NR1H2,ACE).
主要成果:
- 这种药物有效降低了总胆固醇和LDL胆固醇. 根据类型的他类药物,HDL胆固醇的反应有所不同.
- 携带APOE- ε4的患者在服用阿托瓦斯塔丁时显示HDL胆固醇升高. 插入ACE等位基因的携带者显示总和LDL胆固醇较低.
- 特定的CETP单元型和rs11669576基因型调节了对他类药物的反应,影响了总胆固醇,LDL胆固醇,HDL胆固醇和甘油三水平.
结论:
- 阿尔茨海默病患者的脂质状况变化可能由药物遗传因素介导.
- 这些发现强调了AD药物治疗中脂质代谢及其基因变异的显著遗传性.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
869
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
869
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K
Blood Studies for Cardiovascular System III: Serum Lipid Profile
293
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
293
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
38
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
38


